IVA Inventiva S.A.
3.365USD-2.75%Mkt Cap: 794.88M $P/E: —1d ago
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in F…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap794.88M USD
Enterprise Value790.19M USD
Revenue (TTM)2.46M USD
Gross Profit1.92M USD
Net Income (TTM)-354.14M USD
Revenue/Share0.0090 USD
Last Price3.365 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees87
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.61
PEG—
EV/EBITDA-5.30
EV/Revenue321.74
P/S332.79
P/B12.29
EPS (TTM)-0.62
EPS (Forward)-0.75
52W Range
3.1055% of range7.983
52W High7.983 USD
52W Low3.105 USD
Profitability
Gross Margin78.26%
Oper. Margin-5337.32%
EBITDA Margin0.00%
Profit Margin-7899.58%
ROE1241.63%
ROA-141.93%
Growth
Revenue Growth-76.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-104.88M USD
CapEx (TTM)247.00K USD
FCF Margin-4727.97%
FCF Yield-14.61%
Net Debt-27.34M USD
Net Debt/EBITDA0.18
Balance Sheet
Debt/Equity-2.10
Current Ratio3.81
Quick Ratio2.73
Book Value/Sh0.28 USD
Cash/Share0.70 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)15.20 USD
Upside (mean)+351.7%
Target Range10.00 USD – 26.00 USD
10.00+351.7% to mean26.00
# Analysts10
Ownership
Shares Out.236.22M
Float165.57M
Insiders0.00%
Institutions36.99%
Short Interest
Short Ratio4.7d
Short % Float2.18%
Short % Out.2.05%
Shares Short4.85M
Short (prev mo.)2.58M
Technical
SMA 504.301 (-21.8%)
SMA 2005.016 (-32.9%)
Beta1.00
S&P 52W Chg16.45%
Avg Vol (30d)1.96M
Avg Vol (10d)3.41M
Technical Indicators
RSI (14)36.2
MACD-0.2650
MACD Signal-0.2686
MACD Hist.+0.0036
BB Upper4.458 USD
BB Middle3.701 USD
BB Lower2.943 USD
BB Width40.94%
ATR (14)0.2713 USD
Vol Ratio (20d)0.97x